HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ACS 84

a hydrogen sulfide-releasing compound

Also Known As:

ACS84

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Del Soldato, Piero: 3 articles (01/2013 - 01/2011)
2.	Sparatore, Anna: 3 articles (01/2013 - 01/2011)
3.	Bian, Jin-Song: 2 articles (01/2013 - 04/2011)
4.	Dawe, Gavin Stewart: 1 article (01/2013)
5.	Hu, Li-Fang: 1 article (01/2013)
6.	Tazzari, Valerio: 1 article (01/2013)
7.	Teo, Xing Qi: 1 article (01/2013)
8.	Tiong, Chi Xin: 1 article (01/2013)
9.	Xie, Li: 1 article (01/2013)
10.	Liu, Yan-Ying: 1 article (04/2011)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 01/01/2013 - "In conclusion, ACS84 may prevent neurodegeneration via the anti-oxidative mechanism and has potential therapeutic values for Parkinson's disease." 01/01/2013 - "Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model." 01/01/2011 - "The pharmacological profiles of some hybrid lead compounds in the areas of inflammation, H(2)S-donating diclofenac (ACS 15); cardiovascular, H(2)S-donating aspirin (ACS 14); urology, H(2)S-donating sildenafil (ACS 6); and neurodegenerative, H(2)S-donating latanoprost (ACS 67) for glaucoma treatment and H(2)S-donating levodopa (ACS 84) for Parkinson's disease, are described. "
2.	Inflammation (Inflammations) 04/01/2011 - "Taken together, our data suggest that ACS 84 may protect Aβ-induced cell injury via anti-inflammation and preservation of mitochondrial function in a p38 and JNK dependent mechanism. " 01/01/2011 - "The pharmacological profiles of some hybrid lead compounds in the areas of inflammation, H(2)S-donating diclofenac (ACS 15); cardiovascular, H(2)S-donating aspirin (ACS 14); urology, H(2)S-donating sildenafil (ACS 6); and neurodegenerative, H(2)S-donating latanoprost (ACS 67) for glaucoma treatment and H(2)S-donating levodopa (ACS 84) for Parkinson's disease, are described. "
3.	Neurodegenerative Diseases (Neurodegenerative Disease) 04/01/2011 - "Our work suggests that ACS 84 may have potential for the treatment of neurodegenerative diseases."
4.	Glaucoma 01/01/2011 - "The pharmacological profiles of some hybrid lead compounds in the areas of inflammation, H(2)S-donating diclofenac (ACS 15); cardiovascular, H(2)S-donating aspirin (ACS 14); urology, H(2)S-donating sildenafil (ACS 6); and neurodegenerative, H(2)S-donating latanoprost (ACS 67) for glaucoma treatment and H(2)S-donating levodopa (ACS 84) for Parkinson's disease, are described. "

Related Drugs and Biologics

1.	Levodopa (L Dopa)
2.	Therapeutic Uses
3.	Hydrogen Sulfide (Sulfide, Hydrogen)
4.	Diclofenac (SR 38)
5.	Aspirin (Acetylsalicylic Acid)
6.	Latanoprost (Xalatan)
7.	Sildenafil Citrate (Viagra)